ArticleImmunotherapy2018
Intratumoral administration of IL2- and TNF-based fusion proteins cures cancer without establishing protective immunity.
Barbara Ziffels et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it